CABA — CABALETTA BIO INC

Ownership history in SUPERSTRING CAPITAL MANAGEMENT LP  ·  8 quarters on record

This page tracks every 13F SEC filing in which SUPERSTRING CAPITAL MANAGEMENT LP reported a position in CABALETTA BIO INC (CABA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
3.56% (2025 Q3)
Avg. % of fund
1.95%
First filed
2024 Q1
Last filed
2025 Q4
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 2,253,550 +709,025 +45.9% 2.64% $4.9M $2.19
2025 Q3 ADDED 1,544,525 +483,761 +45.6% 3.56% $3.6M $2.34
2025 Q2 ADDED 1,060,764 +601,792 +131.1% 1.91% $1.6M $1.52
2025 Q1 REDUCED 458,972 -363,321 -44.2% 0.76% $636K $1.38
4 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    CABA price (monthly, adj. close)

Other funds also holding CABA

As of 2025 Q4 — sorted by position size

Bain Capital Life Sciences Investors, LLC 3Y 7Y 1.62% Cormorant Asset Management, LP 3Y 7Y 0.45% Stonepine Capital Management, LLC 3Y 7Y 0.27% Opaleye Management Inc. 3Y 7Y 0.26% Almitas Capital LLC 3Y 7Y 0.19% Ikarian Capital, LLC 3Y 0.15% Burkehill Global Management, LP 0.1% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.06% 683 Capital Management, LLC 3Y 7Y 0.04% Dynamic Technology Lab Private Ltd 3Y 7Y 0.03%
← Back to SUPERSTRING CAPITAL MANAGEMENT LP Holdings